Greenwood M C, Doyle D V, Ensor M
Rheumatology Department, Whipps Cross Hospital, Leytonstone, London E11 1NR, UK.
Ann Rheum Dis. 2001 Apr;60(4):344-8. doi: 10.1136/ard.60.4.344.
To assist in the interpretation of the Stanford Health Assessment Questionnaire (HAQ) score changes for individual patients with rheumatoid arthritis (RA), by determining the minimum size of score change that can confidently be considered to reflect a significant change in disability from the patient's perspective.
HAQ score changes were calculated for 40 clinic patients with RA who had reported no change to health in general over two months. These were considered to reflect both inconsistencies in questionnaire completion and any true but minor changes not considered significant enough by the patients to represent a change to their health in general. HAQ score changes over one year were also calculated for 207 clinic patients with RA.
The range within which 95% of score changes would be expected to lie in the absence of significant change was estimated as +/-0.48 points (+/-2SD of the score changes) and 80% within +/-0.31 points (+/-1.29SD). A chi(2) test showed no significant association between an HAQ score increase of >0.31 over one year and decline in health related to arthritis reported by the patient over the same period.
As a general guideline, an HAQ score needs to change by 0.48 points or more for 95% confidence that it reflects significant change (0.31 for 80% confidence). Although the value of HAQ as a group outcome measure is well established, this study questions the usefulness of monitoring individual HAQ scores in a clinical setting.
通过确定能够被自信地认为反映了患者残疾状况显著变化的最小评分变化幅度,协助解读类风湿性关节炎(RA)个体患者的斯坦福健康评估问卷(HAQ)评分变化。
计算了40例临床RA患者的HAQ评分变化,这些患者报告在两个月内总体健康状况无变化。这些变化被认为既反映了问卷填写的不一致性,也反映了任何真实但微小的变化,患者认为这些变化不足以代表其总体健康状况的改变。还计算了207例临床RA患者一年中的HAQ评分变化。
在无显著变化的情况下,预计95%的评分变化范围为±0.48分(评分变化的±2标准差),80%在±0.31分(±1.29标准差)内。一项卡方检验显示,一年内HAQ评分增加>0.31分与患者同期报告的与关节炎相关的健康状况下降之间无显著关联。
作为一般指导原则,HAQ评分需要变化0.48分或更多,才有95%的把握认为它反映了显著变化(变化0.31分有80%的把握)。尽管HAQ作为一种群体结局指标的价值已得到充分确立,但本研究对在临床环境中监测个体HAQ评分的有用性提出了质疑。